Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies
Due: March 7, 2026 This funding opportunity is designed to support research in understanding how to engineer intrinsic characteristics of stem cell-derived islet cell products that can result in improved cell replacement therapy outcomes. Unlike Read More